EpiBone

Other Healthcare Technology Systems · New York, NY · Founded 2013 · Privately Held (backing)

Developer of a bone reconstruction technology designed for skeletal reconstruction through three-dimensional design and living cells. EpiBone is based in New York, NY and was founded in 2013. Its last reported valuation was $44.3 million in Jan 2020. It has raised $71.1 million across 4 recorded rounds; the latest was a $4.3 million seed round in Sep 2025.

Last reported valuation
$44.3M
Oct 2026
Priced at
—
Total raised
$71.1M
Last round
Seed Round
Sep 2025

Who backs EpiBone?

50 investors
InvestorType
Impact AssetsOther
United States Department of War—
Alexandria Venture InvestmentsOther
Hub71Other
Johnson & Johnson Innovation - JLABSOther
Massachusetts Institute of TechnologyOther
Peter ThielHigh net worth
Proxima Ventures (China)Venture capital
Joshua SpearAngel
MBX CapitalVenture capital
+ 40 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

EpiBone investors

50 investors are on record for EpiBone, including Impact Assets, United States Department of War, Alexandria Venture Investments and Hub71. By type, the record holds 10 venture capital firms and 1 angel investor. The seed round in Sep 2025 drew 131 investors.

Free account
More of EpiBone with a free account
  • ·The complete investor list: 50 names
  • ·Watch EpiBone: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 50 firms already write checks for companies like EpiBone in other healthcare technology systems. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View